Key Speakers
• Dr. Sven Stegemann, Director, Pfizer
• Norbert Rasenack, Fellow Inhalation Development, Novartis
• Dr. Jan Möschwitzer, Head Early Pharmaceutical Development, Solvay
• Dr. Oliver Steinbach, Department Head, Philips Research Laboratories
• Joel Richard, Senior Director, Head of Drug Product Development, Ipsen
• Dr. Duncan F Rogers, Reader, National Heart and Lung Institute, Imperial College London
• Dr. Dejan Djuric, R&D Project Management Excipients, BASF
• Dr. Cheryl Barton, Managing Director, Pharmavision
• Gerry Kamstra, Partner, IP & Life Sciences, Bird and Bird
• Prof. Marc Brown, CSO, MedPharm
• Craig Thomson, Attorney, Murgitroyd & Company
• Dr. Giuseppe Battaglia, Lecturer in Bionanotechnology, University of Sheffield
• Dr. Piet Christiaens, Scientific Director, Toxikon Europe
• Dr Pierandrea Esposito, Associate Director, SiTec PharmaBio

Drug delivery continues to be increasingly important sector in the pharmaceutical industry and has undergone rapid growth in the last few years.

Drug delivery technologies are driving growth of pharmaceutical companies and boosting their revenue by extending the product profitable lifecycle through new formulations, combinations and repositioning.

The predominant focus of this conference will be in advancements being made in the drug delivery technologies and understanding the regulatory and legal issues faced by the them.

By attending this conference, you will hear from leaders with expertise in this area their experience and new concepts. It is not to be missed!

Why Attend?

Key benefits:
• Examine the limitations of leading drug delivery technologies
• Discuss the changing patent landscape for drug delivery
• Understand the latest formulation and regulatory standards
• Gain advice on how do effectively develop and maintain drug delivery deal making in this financial climate
• Assess the future of innovations in the drug formulations technologies in the drug industry
• Network with key industry players from pharma, biotech, device and drug delivery industries

Who should attend?

VPs, Directors, Heads, Managers of:
• Drug Delivery
• Preformulation /Formulation/Stability
• Business Development
• Licensing
• Technology Assessment
• Commercial Development
• Patents
• Lifecycle Management
• Strategic Planning and Development
• Financial Analyst
• Pharmaceutical and Analytical R&D
• Pharmaceutical Science
• Testing
• Product Development
• New Product Planning
• New Technology Evaluation
• Marketing
• Brand Management
• Product Management
• Sales
• Regulatory Affairs

Others:
• Intellectual Property Attorneys
• Venture Capitalists
• Medical Device Companies
• Analysts/Investment Banks
• CROs
• Contract Sales Organisations
• Universities and Government Research
• Testing and manufacturing equipment companies
• Packaging companies